C4 Therapeutics, Inc. (CCCC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

490 ARSENAL WAY WATERTOWN, MA 02472

C4 Therapeutics, Inc. operates as a biotechnology company. The Company focuses on novel early stage therapies that eliminate disease-causing proteins for the treatment of cancer, neurological, and other diseases. C4 Therapeutics serves customers in the State of Massachusetts.

Data as of 2021-05-08 12:13:29 -0400
Market Cap1.481 Billion Shares Outstanding43.193 Million Avg 30-day Volume339.132 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-13.25 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low48.97 / 22.4 Next Earnings Date2021-05-13 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CCCC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 0 2 (0.12%) No data
Funds Holding: 76 0 31 (1.86%) No data
13F shares: 22.707 Million 0 13.742 Million No data
% Ownership 52.7702 31.9352 No data
New Positions: 75 31 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CCCC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CCCC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

15 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

15.7 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANDERSON KENNETH CARL

  • Director
292,872 2021-04-14 5

COHEN MARC A

  • Director
  • 10% Owner
4,342,751 2021-04-05 4

COHEN ALAIN J

  • Director
  • 10% Owner
4,204,023 2021-04-05 3

SALTER MALCOLM

  • Director
16,353 2021-04-05 3

CRYSTAL ADAM CHIEF MEDICAL OFFICER

  • Officer
157,292 2021-04-05 2

DUBIN GLENN

  • Director
790,607 2021-03-12 2

FISHER STEWART CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-11 2

SIEGEL JOLIE CHIEF LEGAL OFFICER

  • Officer
0 2021-02-11 1

WAHLBERG LAURA JEAN VP OF FINANCE CORP CONTROLLER

  • Officer
0 2021-02-11 1

DOWNEY BRUCE

  • Director
489,542 2020-10-06 2

PROKUPETS ELENA

  • Director
711,447 2020-10-06 2

MCKEE WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
5,263 2020-10-06 1

HIRSCH ANDREW SEE REMARKS

  • Officer
  • Director
0 2020-10-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ANDERSON KENNETH CARL - Director

2021-04-14 16:39:48 -0400 2021-04-14 M 444 d 4,002 direct

ANDERSON KENNETH CARL - Director

2021-04-14 16:39:48 -0400 2021-04-14 M 267 $2.11 a 84,702 direct -1.1239 -6.288 0.0 1 -7.6853 4

ANDERSON KENNETH CARL - Director

2021-04-14 16:39:48 -0400 2021-04-14 M 267 d 2,940 direct

ANDERSON KENNETH CARL - Director

2021-04-14 16:39:48 -0400 2021-04-14 M 444 $4.98 a 85,146 direct -1.1239 -6.288 0.0 1 -7.6853 4

ANDERSON KENNETH CARL - Director by spouse

2021-04-14 16:39:48 -0400 2021-04-13 G 2,278 a 47,316 indirect -1.1239 -6.288 0.0 1 -7.6853 4

ANDERSON KENNETH CARL - Director

2021-04-14 16:39:48 -0400 2021-04-13 G 2,278 a 84,435 direct -1.1239 -6.288 0.0 1 -7.6853 4

SALTER MALCOLM - Director

2021-04-06 16:30:49 -0400 2021-04-05 A 359 $37.51 a 16,353 direct -6.7736 -8.2665 0.0 1 -15.0954 4

CRYSTAL ADAM - Officer CHIEF MEDICAL OFFICER

2021-04-06 16:30:57 -0400 2021-04-05 S 4,121 $37.16 d 10,879 direct yes -6.7736 -8.2665 0.0 1 -15.0954 4

COHEN MARC A - Director - > 10% Owner

2021-04-06 16:30:24 -0400 2021-04-05 A 553 $37.51 a 6,119 direct -6.7736 -8.2665 0.0 1 -15.0954 4

CRYSTAL ADAM - Officer CHIEF MEDICAL OFFICER

2021-04-06 16:30:57 -0400 2021-04-05 M 15,000 d 157,292 direct yes

CRYSTAL ADAM - Officer CHIEF MEDICAL OFFICER

2021-04-06 16:30:57 -0400 2021-04-05 M 15,000 $6.50 a 15,000 direct yes -6.7736 -8.2665 0.0 1 -15.0954 4

COHEN ALAIN J - Director - > 10% Owner

2021-04-06 16:30:31 -0400 2021-04-05 A 266 $37.51 a 266 direct -6.7736 -8.2665 0.0 1 -15.0954 4

CRYSTAL ADAM - Officer CHIEF MEDICAL OFFICER

2021-04-06 16:30:57 -0400 2021-04-05 S 10,879 $38.00 d 0 direct yes -6.7736 -8.2665 0.0 1 -15.0954 4

ANDERSON KENNETH CARL - Director

2021-04-06 16:31:07 -0400 2021-04-05 A 233 $37.51 a 82,157 direct -6.7736 -8.2665 0.0 1 -15.0954 4

DUBIN GLENN - Director

2021-03-16 16:17:42 -0400 2021-03-12 A 41,200 a 41,200 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
C4 THERAPEUTICS INC CCCC 2021-05-10 22:15:04 UTC -0.7247 0.7747 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 21:45:02 UTC -0.7247 0.7747 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 21:15:02 UTC -0.7247 0.7747 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 20:45:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 20:15:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 19:45:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 19:15:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 18:45:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 18:15:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 17:45:02 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 17:15:03 UTC -0.7331 0.7831 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 16:45:03 UTC -0.9288 0.9788 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 16:15:03 UTC -0.9288 0.9788 450000
C4 THERAPEUTICS INC CCCC 2021-05-10 15:45:03 UTC -0.9288 0.9788 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 15:15:03 UTC -0.9288 0.9788 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 14:45:04 UTC -0.7657 0.8157 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 14:15:04 UTC -0.7657 0.8157 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 13:45:04 UTC -0.7657 0.8157 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 13:15:03 UTC -0.7657 0.8157 100000
C4 THERAPEUTICS INC CCCC 2021-05-10 12:45:02 UTC -0.7657 0.8157 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments